Senza Omnia News Today

REDWOOD CITY, Calif., May 24, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO ), a global medical device company that is delivering comprehensive, life

Medigus (NASDAQ:MDGS – Get Free Report) and Nevro (NYSE:NVRO – Get Free Report) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends. Profitability This table compares Medigus and Nevro’s net […]

Nevro Corp. (NYSE:NVRO – Get Free Report)’s share price fell 4.8% during trading on Monday . The company traded as low as $13.58 and last traded at $13.75. 22,683 shares were traded during trading, a decline of 95% from the average session volume of 481,205 shares. The stock had previously closed at $14.44. Analyst Upgrades […]

Nevro Corp. (NYSE:NVRO – Get Free Report) has received an average rating of “Hold” from the thirteen analysts that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, eleven have issued a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month […]

Nevro Corp. (NYSE:NVRO – Get Free Report) has earned a consensus recommendation of “Hold” from the thirteen research firms that are currently covering the stock, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, eleven have assigned a hold recommendation and one has assigned a buy recommendation to the company. The […]

Oppenheimer lowered shares of Nevro (NYSE:NVRO – Free Report) from an outperform rating to a market perform rating in a research report released on Thursday, MarketBeat.com reports. NVRO has been the topic of several other research reports. StockNews.com raised Nevro from a sell rating to a hold rating in a research note on Wednesday, February […]

Nevro (NYSE:NVRO – Free Report) had its target price trimmed by Wells Fargo & Company from $20.00 to $17.00 in a report released on Thursday morning, Benzinga reports. They currently have an equal weight rating on the medical equipment provider’s stock. Other equities analysts also recently issued reports about the stock. JPMorgan Chase & Co. […]

Nevro (NYSE:NVRO – Get Free Report) had its price target dropped by research analysts at Robert W. Baird from $23.00 to $19.00 in a research report issued to clients and investors on Thursday, Benzinga reports. The firm currently has a “neutral” rating on the medical equipment provider’s stock. Robert W. Baird’s price target indicates a […]

Nevro (NYSE:NVRO – Get Free Report) is scheduled to announce its earnings results after the market closes on Wednesday, February 21st. Analysts expect the company to announce earnings of ($0.50) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. Nevro Price Performance Shares […]

Nevro (NYSE:NVRO – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a research note issued to investors on Wednesday. Other research analysts have also issued research reports about the company. Royal Bank of Canada lowered Nevro from an “outperform” rating to a “sector […]